Benitec Biopharma Inc.
BNTC
$12.37
-$0.63-4.85%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -48.88M | -51.45M | -49.17M | -45.26M | -33.83M |
| Total Depreciation and Amortization | 475.00K | 462.00K | 423.00K | 396.00K | 369.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 33.60M | 33.75M | 28.75M | 24.00M | 11.01M |
| Change in Net Operating Assets | -4.99M | -1.19M | -2.36M | -2.73M | 3.79M |
| Cash from Operations | -19.79M | -18.43M | -22.35M | -23.59M | -18.67M |
| Capital Expenditure | -26.00K | -17.00K | -18.00K | -18.00K | -18.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -26.00K | -17.00K | -18.00K | -18.00K | -18.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 147.35M | 177.30M | 90.68M | 112.33M | 113.03M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -46.07M | -48.31M | -42.05M | -42.05M | -5.21M |
| Cash from Financing | 101.28M | 128.99M | 48.63M | 70.29M | 107.81M |
| Foreign Exchange rate Adjustments | -233.00K | -187.00K | 230.00K | 49.00K | 164.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 81.23M | 110.36M | 26.49M | 46.73M | 89.29M |